Ethics in Research: - Vanderbilt School of Medicine
Ethics in Research: - Vanderbilt School of Medicine
Ethics in Research: - Vanderbilt School of Medicine
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Ethics</strong> <strong>in</strong> <strong>Research</strong>:<br />
A Retrospective on <strong>Research</strong> Integrity,<br />
<strong>Research</strong> Misconduct, and <strong>Research</strong> Policy<br />
Elizabeth Heitman, PhD<br />
<strong>Vanderbilt</strong> University Medical Center<br />
Center for Biomedical <strong>Ethics</strong> and Society
The transition from tra<strong>in</strong>ee to funded<br />
faculty <strong>in</strong>vestigator is marked by<br />
<strong>in</strong>creas<strong>in</strong>g levels <strong>of</strong> responsibility for<br />
the policies and practices essential to<br />
good research.
Where do policies on<br />
“research ethics” come from?<br />
• Federal government<br />
• State and local government<br />
• Pr<strong>of</strong>essional organizations<br />
• Institutions<br />
• Laboratories and work groups
Most research policy comes from<br />
federal efforts to promote<br />
standards <strong>of</strong> ethics, health, and<br />
safety <strong>in</strong> research.<br />
NIH requires all funded <strong>in</strong>stitutions<br />
and <strong>in</strong>vestigators to comply with a<br />
host <strong>of</strong> policies govern<strong>in</strong>g ethics and<br />
research <strong>in</strong>tegrity.
NIH fund<strong>in</strong>g to <strong>in</strong>stitutions is cont<strong>in</strong>gent on<br />
compliance with these and other policies,<br />
spelled out by <strong>in</strong>stitutional contract.<br />
• Debarment and Suspension<br />
• Drug-Free / Smoke-Free<br />
Workplace<br />
• Seat Belt Use<br />
• Lobby<strong>in</strong>g<br />
• F<strong>in</strong>ancial Conflict <strong>of</strong> Interest<br />
• <strong>Research</strong> Misconduct<br />
• Data Management / Shar<strong>in</strong>g<br />
• Nondel<strong>in</strong>quency on Federal Debt<br />
• Human Embryonic Stem Cell<br />
<strong>Research</strong><br />
• Effort Report<strong>in</strong>g<br />
• Human Subjects/ Required<br />
Education on Protection <strong>of</strong><br />
Human Subjects<br />
• <strong>Research</strong> on Fetal Tissue<br />
• Recomb<strong>in</strong>ant DNA / Human<br />
Gene Transfer <strong>Research</strong><br />
• Vertebrate Animals<br />
• Inclusion <strong>of</strong> Women, Children,<br />
and M<strong>in</strong>ority Participants
Objectives<br />
• Consider the development <strong>of</strong> federal and<br />
<strong>in</strong>stitutional policies on research <strong>in</strong>tegrity<br />
• Exam<strong>in</strong>e some historical revelations <strong>of</strong> scientific<br />
misconduct and the discussion <strong>of</strong> research<br />
<strong>in</strong>tegrity that led to many policies<br />
• Consider the current dual emphasis on<br />
<strong>in</strong>dividual and <strong>in</strong>stitutional <strong>in</strong>tegrity and their<br />
mean<strong>in</strong>g for postdoctoral fellows
Irony <strong>of</strong> <strong>Ethics</strong> <strong>in</strong> History<br />
• Insight and reform come more <strong>of</strong>ten from<br />
scandal and catastrophe than from reflection <strong>in</strong><br />
good times.<br />
• Authoritative ethical standards for research have<br />
typically been developed <strong>in</strong> response to<br />
misconduct or scientific changes that pose<br />
significant new risks.<br />
• Ethical standards <strong>of</strong>ten come as external<br />
regulation and <strong>in</strong>stitutional oversight; <strong>in</strong>ternal<br />
pr<strong>of</strong>essional debate is crucial but less visible.
Ethical ideals for research developed<br />
alongside practical methodologies as the<br />
scientific community became established.<br />
• Honesty and truthfulness<br />
• Objectivity and rationality<br />
• Skepticism, self-criticism, and peer-review<br />
review<br />
• Openness, trust, and communalism<br />
• Intellectual freedom and tolerance
Medical research pre-1920 was<br />
governed by Hippocratic ethics<br />
• Few doctors were tra<strong>in</strong>ed <strong>in</strong> experimental<br />
theory or scientific techniques<br />
• Most experimentation was conducted by<br />
physicians as part <strong>of</strong> therapy – both doctor<br />
and patient saw experimentation as <strong>in</strong> the<br />
patient’s s <strong>in</strong>terest<br />
• Emphasis on patient’s s welfare <strong>in</strong> the event <strong>of</strong><br />
a conflict between science and therapy
The growth <strong>of</strong> science and demand for<br />
benefit stretched the unwritten norms<br />
<strong>of</strong> biomedical research, creat<strong>in</strong>g<br />
greater need for clearly articulated<br />
standards.<br />
• Development <strong>of</strong> new specialty fields<br />
decreased common knowledge, identity,<br />
and values among researchers.<br />
• Heightened need for skepticism AND<br />
trust among researchers
<strong>Research</strong>ers had little reason to articulate<br />
their ethical norms until moral crises<br />
forced them to spell out standards to<br />
judge wrongdo<strong>in</strong>g.<br />
Today’s s formal statements and policies on<br />
research ethics have been developed<br />
largely <strong>in</strong> response to apparent violations <strong>of</strong><br />
unwritten pr<strong>of</strong>essional expectations.
Ethical scandals and new technologies<br />
forced researchers to articulate ethical<br />
standards <strong>in</strong> several key areas:<br />
• Human research<br />
• Animal research<br />
• Biological safety<br />
• Scientific <strong>in</strong>tegrity<br />
Formal standards also led to the creation <strong>of</strong> new<br />
structures to oversee them.
Discovery <strong>of</strong> Nazi researchers’<br />
abuse <strong>of</strong> human subjects led to<br />
the 1949 Nuremberg Code, the<br />
ethical standard by which Nazi<br />
medical war crimes were judged.<br />
Pr<strong>in</strong>ciple 1. “The voluntary consent <strong>of</strong> the<br />
human subject is absolutely essential.”
Increased attention focused on def<strong>in</strong><strong>in</strong>g<br />
<strong>in</strong>formed consent and researchers’ and<br />
<strong>in</strong>stitutions’ responsibility to human<br />
subjects:<br />
• WMA Declaration <strong>of</strong> Hels<strong>in</strong>ki - 1964<br />
• Henry Beecher’s s exposé - 1966<br />
• Creation <strong>of</strong> IRBs - 1966<br />
• USPHS (Tuskegee) Syphilis Trial - 1972<br />
• National <strong>Research</strong> Act - 1974<br />
• Belmont Report - 1979<br />
• Respect for persons, beneficence, justice
US regulation <strong>of</strong> animal research began <strong>in</strong><br />
response to a 1966 pet-napp<strong>in</strong>g scandal.<br />
• The Laboratory Animal Welfare Act – 1966<br />
• Prevention <strong>of</strong> theft <strong>of</strong> pets through recordkeep<strong>in</strong>g<br />
• Standards for hous<strong>in</strong>g and care<br />
• Exclusion <strong>of</strong> birds and rodents – 1972<br />
• PHS Policy on Humane Care and Use <strong>of</strong> Animals, with<br />
<strong>in</strong>stitutional review – 1971<br />
• Revisions mandated IACUC – 1986<br />
• National <strong>Research</strong> Council’s Guide - 1996
Recomb<strong>in</strong>ant DNA research <strong>in</strong> the 1970s<br />
raised new questions about risks <strong>of</strong><br />
un<strong>in</strong>tended harms from new organisms.<br />
• NAS moratorium on rDNA work – 1974<br />
• Asilomar statement – 1975<br />
• Conta<strong>in</strong>ment to match risk<br />
• Pr<strong>of</strong>essional standards self-imposed<br />
• Institutional Biosafety Committees (IBCs(<br />
IBCs) ) to<br />
review NIH-funded<br />
rDNA protocols<br />
• Expansion to broader ID research<br />
• Biosecurity and dual-use use research post-9/11?
By the mid 1970s, federal regulatory<br />
bodies provided some policy and<br />
oversight <strong>of</strong> biomedical science <strong>in</strong> :<br />
• Human research<br />
• Animal research<br />
• Biological safety
Through the debates on the ethics<br />
and risks <strong>of</strong> biomedical research <strong>in</strong><br />
the 1960s-1970s, 1970s, no one questioned<br />
the quality <strong>of</strong> the science.<br />
In the 1980s, revelations <strong>of</strong> “fraud” by<br />
prom<strong>in</strong>ent researchers prompted<br />
journalistic <strong>in</strong>quiry and Congressional<br />
review.
High-pr<strong>of</strong>ile Cases <strong>of</strong> Misconduct<br />
• William Summerl<strong>in</strong>, , MD – 1975<br />
• Robert Slutsky, , MD – 1985<br />
• John Darsee, , MD – 1981<br />
• Stephen Breun<strong>in</strong>g, , PhD – 1983<br />
• Thereza Imanishi-Kari, PhD and David<br />
Baltimore, PhD – 1986<br />
• Robert Gallo – 1991
Science writers explored fraud and error<br />
<strong>in</strong> biomedical science <strong>in</strong> the early 1980s<br />
• Betrayers <strong>of</strong> the Truth – 1982<br />
• NY Times science writers’ William Broad &<br />
Nicholas Wade<br />
• False Prophets -1986 and 1989<br />
• Virologist/ editor <strong>of</strong> Journal <strong>of</strong> Irreproducible<br />
Results<br />
They also looked for misconduct <strong>in</strong><br />
history, identify<strong>in</strong>g prom<strong>in</strong>ent figures’<br />
apparent wrongdo<strong>in</strong>g.
Historical Cases <strong>of</strong> Self-Deception,<br />
Error, and Misconduct<br />
• Ptolemy – fabricated observations?<br />
• Newton – falsified measurements ?<br />
• Mendel – trimmed data to fit hypothesis?<br />
• Pasteur – plagiarized?<br />
• Carrel – self-deception?<br />
• Burt – fabricated data and collaborators?<br />
• Millikan – plagiarized student’s s work?<br />
• Watson and Crick – plagiarized stolen work?
Seem<strong>in</strong>gly limited attention from the<br />
scientific community and research<br />
<strong>in</strong>stitutions prompted formal<br />
<strong>in</strong>vestigation by the U.S. House<br />
Subcommittee on Oversight and<br />
Investigations, chaired by Rep. John<br />
D<strong>in</strong>gell <strong>in</strong> 1986.<br />
Public outcry and crim<strong>in</strong>al <strong>in</strong>dictments for<br />
misuse <strong>of</strong> federal funds resulted.
Congressional hear<strong>in</strong>gs with prom<strong>in</strong>ent<br />
biomedical researchers, <strong>in</strong>clud<strong>in</strong>g David<br />
Baltimore, led Congress to seek to<br />
protect US taxpayers’ money through<br />
<strong>in</strong>creased federal control over research.<br />
• NIH Office <strong>of</strong> Scientific Integrity - 1989<br />
• DHHS Office <strong>of</strong> Scientific Integrity Review -1989<br />
• Merged as Office <strong>of</strong> <strong>Research</strong> Integrity (ORI) - 1992
DHHS Def<strong>in</strong>ition <strong>of</strong> Misconduct - 1989<br />
…fabrication, falsification, plagiarism, or other<br />
practices that seriously deviate from those<br />
that are commonly accepted with<strong>in</strong> the<br />
scientific community for propos<strong>in</strong>g,<br />
conduct<strong>in</strong>g, or report<strong>in</strong>g research. It does not<br />
<strong>in</strong>clude honest error or honest differences <strong>in</strong><br />
<strong>in</strong>terpretations or judgments <strong>of</strong> data.<br />
(54 FR 32449, Aug. 8, 1989)
DHHS Required Misconduct Policy<br />
Funded <strong>in</strong>stitutions were also<br />
required to establish a mechanism<br />
for the report<strong>in</strong>g and <strong>in</strong>vestigation <strong>of</strong><br />
suspicions <strong>of</strong> misconduct and, later,<br />
the protection <strong>of</strong> whistleblowers.
Pr<strong>of</strong>essional societies and government<br />
agencies promoted education rather than<br />
oversight as the key to scientific <strong>in</strong>tegrity.<br />
• IOM called for “formal <strong>in</strong>struction <strong>in</strong> good research practices”<br />
(1989)<br />
• NIH required NRSA tra<strong>in</strong><strong>in</strong>g grants to <strong>in</strong>clude “plans for<br />
<strong>in</strong>struction <strong>in</strong> the responsible conduct <strong>of</strong> research” (1989)<br />
• NAS called for “programs that foster faculty and student<br />
awareness <strong>of</strong> ... the <strong>in</strong>tegrity <strong>of</strong> the research process” (1992)<br />
• DHHS Commission on <strong>Research</strong> Integrity urged NIH to certify<br />
that federally funded research <strong>in</strong>stitutions had an educational<br />
program on RCR (1995)
DHHS/ORI announced all <strong>in</strong>stitutions must<br />
provide RCR tra<strong>in</strong><strong>in</strong>g to all engaged <strong>in</strong> PHS-<br />
funded research or research tra<strong>in</strong><strong>in</strong>g (2000)<br />
• Data management<br />
• Mentor/tra<strong>in</strong>ee responsibilities<br />
• Publication and authorship<br />
• Peer review<br />
• Collaborative science<br />
• <strong>Research</strong> with human be<strong>in</strong>gs<br />
• <strong>Research</strong> <strong>in</strong>volv<strong>in</strong>g animals<br />
• <strong>Research</strong> misconduct<br />
• Conflict <strong>of</strong> <strong>in</strong>terest and commitment
F<strong>in</strong>al Def<strong>in</strong>ition <strong>of</strong> <strong>Research</strong> Misconduct<br />
Fabrication is mak<strong>in</strong>g up data or results and<br />
record<strong>in</strong>g or report<strong>in</strong>g them.<br />
Falsification is manipulat<strong>in</strong>g research materials,<br />
equipment, or processes, or chang<strong>in</strong>g or omitt<strong>in</strong>g data<br />
or results such that the research is not accurately<br />
represented <strong>in</strong> the research record.<br />
Plagiarism is the appropriation <strong>of</strong> another person's<br />
ideas, processes, results, or words without giv<strong>in</strong>g<br />
appropriate credit. (65 FR 76260-76264, 76264, Dec. 6, 2000)
Government regulation and <strong>in</strong>stitutional<br />
oversight <strong>of</strong> human research cont<strong>in</strong>ued to<br />
grow throughout the 1990s:<br />
• Common Rule (45 CFR 46) - 1991<br />
• Revised standards for research with vulnerable<br />
populations - 1993 & 1998<br />
• Presidents’ Advisory Committee on Human<br />
Radiation Experiments - 1994<br />
• Cl<strong>in</strong>ton’s s Apology for the Syphilis Trial – 1997<br />
• Suspensions at Duke et al. – 1999<br />
• Mandated IRB tra<strong>in</strong><strong>in</strong>g - 1999<br />
• Reorganization <strong>of</strong> OPRR <strong>in</strong>to OHRP – 2001
Congressional and pr<strong>of</strong>essional criticism<br />
prompted ORI to withdraw its universal<br />
RCR educational policy <strong>in</strong> February 2001<br />
Many <strong>in</strong>stitutions had already begun to expand their<br />
tra<strong>in</strong><strong>in</strong>g grant RCR programs to all researchers.<br />
Many pr<strong>of</strong>essional societies, research organizations,<br />
and government agencies had already begun to<br />
articulate standards and formal policies.<br />
Some <strong>in</strong>stitutions implemented universal RCR tra<strong>in</strong><strong>in</strong>g<br />
for compliance standards “just <strong>in</strong> case”.
IOM’s s 2002 report “Integrity <strong>in</strong> Scientific<br />
<strong>Research</strong>” def<strong>in</strong>ed <strong>in</strong>tegrity at two levels:<br />
Individual <strong>in</strong>tegrity = commitment to <strong>in</strong>tellectual<br />
honesty and personal responsibility that<br />
characterizes responsible conduct <strong>in</strong> research<br />
Institutional <strong>in</strong>tegrity = creation <strong>of</strong> an environment<br />
that promotes responsible conduct and fosters<br />
<strong>in</strong>tegrity through structures, processes, policies,<br />
and procedures
Individual-level level Integrity<br />
• Intellectual honesty<br />
• Accuracy <strong>in</strong> represent<strong>in</strong>g one’s s contributions<br />
• Fairness <strong>in</strong> peer review<br />
• Collegiality <strong>in</strong> communications and shar<strong>in</strong>g <strong>of</strong><br />
resources<br />
• Transparency <strong>in</strong> real or potential conflicts <strong>of</strong> <strong>in</strong>terest<br />
• Protection <strong>of</strong> human subjects <strong>in</strong> research<br />
• Humane use <strong>of</strong> animals<br />
• Adherence to the mutual responsibilities <strong>of</strong> team<br />
members
Policies Support<strong>in</strong>g Institutional Integrity<br />
• <strong>Research</strong> Misconduct<br />
• Debarment and Suspension<br />
• F<strong>in</strong>ancial Conflict <strong>of</strong> Interest<br />
• Data Management and Shar<strong>in</strong>g<br />
• Protection <strong>of</strong> Human Participants<br />
• Vertebrate Animals<br />
• Recomb<strong>in</strong>ant DNA /Human Gene Transfer<br />
<strong>Research</strong><br />
• Mentor<strong>in</strong>g<br />
• Appo<strong>in</strong>tment, Promotion and Tenure
Where Do We Stand?<br />
• Debate has helped to articulate areas <strong>of</strong><br />
concern for researchers and <strong>in</strong>stitutions<br />
• Statements <strong>of</strong> standards <strong>of</strong> practice and<br />
formal pr<strong>of</strong>essional guidel<strong>in</strong>es be<strong>in</strong>g<br />
developed<br />
• Emphasis on education for new tra<strong>in</strong>ees,<br />
clarification for practic<strong>in</strong>g researchers<br />
• Emphasis on compliance confuses ethics
Obstacles to Institutional Integrity<br />
• Good policy does not ensure good practice<br />
• Compliance is necessary but not sufficient<br />
• Compliance generally concerns m<strong>in</strong>imum standards,<br />
not model behavior<br />
• Standards for compliance may conflict<br />
• Standards for compliance may not fit new situations<br />
• Emphasis on compliance alone may breed cynicism
Obstacles to Institutional Integrity<br />
• Good policy does not ensure good practice<br />
• Compliance is necessary but not sufficient<br />
• Compliance generally concerns m<strong>in</strong>imum standards,<br />
not model behavior<br />
• Standards for compliance may conflict<br />
• Standards for compliance may not fit new situations<br />
• Emphasis on compliance alone may breed cynicism
The <strong>Research</strong> Environment and<br />
Organizational Context <strong>of</strong> <strong>Research</strong><br />
• Normal Misbehaviors: Scientists Talk<br />
About the <strong>Ethics</strong> <strong>of</strong> <strong>Research</strong> – Raymond<br />
De Vries, Melissa S. Anderson, Brian C. Mart<strong>in</strong>son,<br />
JERHRE 2006; 1: 43-50.<br />
• Scientists Perception <strong>of</strong> Organizational<br />
Justice and Self-Reported Misbehaviors<br />
– Brian C. Mart<strong>in</strong>son, Melissa S. Anderson, A.<br />
Lauren Cra<strong>in</strong>, Raymond De Vries, JERHRE 2006; 1:<br />
51-66.
• Mean<strong>in</strong>g <strong>of</strong> data<br />
“Normal Misbehaviors”<br />
• Keep<strong>in</strong>g notes<br />
• Cook<strong>in</strong>g and clean<strong>in</strong>g<br />
• Rules <strong>of</strong> science<br />
• Whose rules, when<br />
• Details and big picture<br />
• Life with colleagues<br />
• Oversight is hard on relationships<br />
• Competition and corruption<br />
• Pressures <strong>of</strong> production<br />
• Gett<strong>in</strong>g fund<strong>in</strong>g do to work to get fund<strong>in</strong>g<br />
• More competition
The <strong>Research</strong> Environment and<br />
Organizational Context <strong>of</strong> <strong>Research</strong><br />
• Policy focus on FFP fails to address more<br />
prevalent “normal misbehavior” that is harmful<br />
but harder to track.<br />
• Normal misbehavior allows scientists to deal with<br />
uncerta<strong>in</strong>ties on the frontier <strong>of</strong> knowledge.<br />
• Normal misbehavior illustrates “p<strong>in</strong>ch po<strong>in</strong>ts”<br />
where policy and social structures <strong>of</strong> science and<br />
research <strong>in</strong>stitutions create stra<strong>in</strong>.<br />
• Ord<strong>in</strong>ary and extraord<strong>in</strong>ary misbehavior need<br />
attention.
The <strong>Research</strong> Environment and<br />
Organizational Context <strong>of</strong> <strong>Research</strong><br />
• Organizational justice affects both dramatic and<br />
normal misbehavior.<br />
• Mid career and junior researchers perceive<br />
unfairness <strong>in</strong> the rules and processes <strong>of</strong> research,<br />
and their research <strong>in</strong>stitution and environments.<br />
• Ord<strong>in</strong>ary and extraord<strong>in</strong>ary misbehavior more<br />
likely among researchers who perceive unfairness<br />
– misbehavior is <strong>of</strong>ten an attempt to level the<br />
play<strong>in</strong>g field.<br />
• Perception and reality are not dist<strong>in</strong>guishable.
Organizational culture is crucial to<br />
<strong>in</strong>stitutional <strong>in</strong>tegrity.<br />
Institutional <strong>in</strong>tegrity equates excellent<br />
research with <strong>in</strong>tegrity as well as with<br />
productivity.<br />
“We do good work” – “This is a good place to work”
THE POLITICS OF SCIENTIFIC<br />
MISCONDUCT AND FRAUD<br />
When: Tuesday, March 20, 2007<br />
Where: University <strong>of</strong> Vienna<br />
Dept. <strong>of</strong> Political Science .<br />
Conference Room, 2nd Floor<br />
Universitätsstrasse<br />
tsstrasse 7<br />
1010 Vienna, Austria